Literature DB >> 7624318

Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells.

G A Ward1, C K Stover, B Moss, T R Fuerst.   

Abstract

We developed a stringently regulated expression system for mammalian cells that uses (i) the RNA polymerase, phi 10 promoter, and T phi transcriptional terminator of bacteriophage T7; (ii) the lac repressor, lac operator, rho-independent transcriptional terminators and the gpt gene of Escherichia coli; (iii) the RNA translational enhancer of encephalomyocarditis virus; and (iv) the genetic background of vaccinia virus. In cells infected with the recombinant vaccinia virus, reporter beta-galactosidase synthesis was not detected in the absence of inducer. An induction of at least 10,000- to 20,000-fold occurred upon addition of isopropyl beta-D-thiogalactopyranoside or by temperature elevation from 30 to 37 degrees C using a temperature-sensitive lac repressor. Regulated synthesis of the secreted and highly glycosylated human immunodeficiency virus 1 envelope protein gp120 was also demonstrated. Yields of both proteins were approximately 2 mg per 10(8) cells in 24 hr. Plasmid transfer vectors for cloning and expression of complete or incomplete open reading frames in recombinant vaccinia viruses are described.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624318      PMCID: PMC41411          DOI: 10.1073/pnas.92.15.6773

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Controlling basal expression in an inducible T7 expression system by blocking the target T7 promoter with lac repressor.

Authors:  J W Dubendorff; F W Studier
Journal:  J Mol Biol       Date:  1991-05-05       Impact factor: 5.469

2.  Genetic studies of the lac repressor. XIII. Extensive amino acid replacements generated by the use of natural and synthetic nonsense suppressors.

Authors:  L G Kleina; J H Miller
Journal:  J Mol Biol       Date:  1990-03-20       Impact factor: 5.469

3.  Structure of vaccinia virus early promoters.

Authors:  A J Davison; B Moss
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

4.  Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis.

Authors:  Y Ichihashi; S Dales
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

5.  In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals.

Authors:  M A Cochran; C Puckett; B Moss
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

6.  Viable double vaccinia virus recombinants with the non-inducible phage T7 expression system.

Authors:  M V Kriajevska; L G Zakharova; A D Altstein
Journal:  J Gen Virol       Date:  1993-01       Impact factor: 3.891

7.  Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor.

Authors:  W A Alexander; B Moss; T R Fuerst
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 8.  Vaccinia virus: a tool for research and vaccine development.

Authors:  B Moss
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

9.  Analysis of inducers of the E.coli lac repressor system in mammalian cells and whole animals.

Authors:  D L Wyborski; J M Short
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

10.  Functional interrelationship between two tandem E. coli ribosomal RNA promoters.

Authors:  G Glaser; P Sarmientos; M Cashel
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

View more
  73 in total

1.  Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase.

Authors:  T Betakova; E J Wolffe; B Moss
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.

Authors:  W H Zhang; D Wilcock; G L Smith
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Recombinant vaccinia viruses. Design, generation, and isolation.

Authors:  C C Broder; P L Earl
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

4.  Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes.

Authors:  A D Garcia; B Moss
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.

Authors:  W W Yeh; B Moss; E J Wolffe
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Interaction between hepatitis B virus core protein and reverse transcriptase.

Authors:  L Lott; B Beames; L Notvall; R E Lanford
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Evidence for an essential catalytic role of the F10 protein kinase in vaccinia virus morphogenesis.

Authors:  Patricia Szajner; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components.

Authors:  Camilo Ansarah-Sobrinho; Bernard Moss
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.